5-(1,3-DIOXOLAN-2-YL)-2,3,4-TRIFLUORO-N-HYDROXY-N'-((1S)-2-HYDROXY-1-METHYLETHYL)BENZENECARBOXIMIDAMIDE
UNII MGR2U4B4BJ
Substance Identification & Data
This profile provides standardized clinical and technical data for 5-(1,3-dioxolan-2-yl)-2,3,4-trifluoro-n-hydroxy-n'-((1s)-2-hydroxy-1-methylethyl)benzenecarboximidamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MGR2U4B4BJ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1802090-19-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C13H15F3N2O4 KAKRSPMUZQIKNH-LURJTMIESA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 5-(1,3-dioxolan-2-yl)-2,3,4-trifluoro-n-hydroxy-n'-((1s)-2-hydroxy-1-methylethyl)benzenecarboximidamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.